A large systematic review on pregnant women living with HIV found that protease inhibitor–based antiretroviral therapy (ART) use was associated with increased risk of babies being born small or very ...
Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.
The first antiretroviral therapies (ARTs) for people with HIV were nucleoside reverse-transcriptase inhibitors (NRTIs), but these drugs were only partially effective. The addition of an orally ...
September 6, 2007 — The human immunodeficiency virus (HIV) protease inhibitor nelfinavir ( Viracept, Pfizer) has shown anticancer activity in cell cultures and in animal studies, and the drug is now ...
HIV-1 protease inhibitors (PIs) have long been central to antiretroviral therapy, directly targeting the enzyme responsible for processing viral polyproteins into functional units. Their efficacy, ...
Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria, according to a study published in the December 15 issue of The Journal of Infectious ...
A preliminary study to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April), suggests that people living with HIV who ...
Association between FDG-PET and tumor vitality: Understanding the prognostic value of FDG uptake in early stage non-small cell lung cancer No significant financial relationships to disclose. This is ...
Research Triangle Park, N.C., Oct. 21, 2003 – GlaxoSmithKline (GSK) today announced that the Food and Drug Administration has granted marketing clearance for Lexiva™ (fosamprenavir calcium) ...
Nelfinavir mesylate administered with concurrent chemoradiotherapy appeared associated with promising responses and survival outcomes among patients with locally advanced non-small cell lung cancer, ...
HIV, the pandemic virus that causes AIDS, kills 2 million people each year worldwide. Malaria, a pervasive parasite spread by mosquitoes, infects 225 million people and kills 781,000 annually. The ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This article is more than 4 years old. SARS Inhibited (2006 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback